+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07206225

Evaluating PF-08052667 Alone and With BCG andor Sasanlimab for Adults With Non-Muscle Invasive Bladder Cancer

Led by Pfizer · Updated on 2026-10-13

294

Participants Needed

68

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how a new medicine called PF-08052667 works alone or combined with Bacillus Calmette Guerin BCG andor sasanlimab in adults with a type of bladder cancer that has not spread into the muscle layer but is more likely to come back or grow. This study includes people whose cancer has returned or persisted despite standard treatments like BCG, as well as those who cannot receive or do not have access to standard treatments. The study is a phase 1 trial with three parts to test different dosing and combinations of these medicines. Participants receive PF-08052667 as an intravesical infusion directly into the bladder on days 1, 8, and 15 of a 21-day cycle. In Part 2 and Part 3, PF-08052667 is combined with BCG andor sasanlimab, with sasanlimab given as a subcutaneous injection under the skin. The study has three parts Part 1 tests increasing doses of PF-08052667 alone Part 2 tests combinations of PF-08052667 with BCG andor sasanlimab and Part 3 further explores optimal doses and combinations, including participants who have never had standard treatments. Participants will continue treatment until they choose to stop, are withdrawn for reasons such as side effects, or for up to about two years. Long-term follow-up will continue after treatment ends until loss to follow-up, death, or study completion. Researchers will monitor safety, side effects, lab results, and tumor responses, including recurrence-free and event-free survival. Participation duration varies based on individual circumstances and study progress.

CONDITIONS

Brief Title

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Research Team

P

Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here